Octreotide Acetate (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Octreotide Acetate drug offered from Teva Parenteral Medicines, Inc.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
| NON-PROPRIETARY NAME: | Octreotide Acetate |
| SUBSTANCE NAME: | OCTREOTIDE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2005-11-14 |
| END MARKETING DATE: | 0000-00-00 |
Octreotide Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Octreotide Acetate from Teva Parenteral Medicines, Inc. |
| LABELER NAME: | Teva Parenteral Medicines, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(ug/mL) |
| START MARKETING DATE: | 2005-11-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0703-3301_bfb154d8-b9fc-4a06-9f79-d5f3ee882fd7 |
| PRODUCT NDC: | 0703-3301 |
| APPLICATION NUMBER: | ANDA075957 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers:
